Roger Royster to Dobutamine
This is a "connection" page, showing publications Roger Royster has written about Dobutamine.
Connection Strength
0.305
-
MacGregor DA, Butterworth JF, Zaloga CP, Prielipp RC, James R, Royster RL. Hemodynamic and renal effects of dopexamine and dobutamine in patients with reduced cardiac output following coronary artery bypass grafting. Chest. 1994 Sep; 106(3):835-41.
Score: 0.124
-
Butterworth JF, Zaloga GP, Prielipp RC, Tucker WY, Royster RL. Calcium inhibits the cardiac stimulating properties of dobutamine but not of amrinone. Chest. 1992 Jan; 101(1):174-80.
Score: 0.103
-
Prielipp RC, MacGregor DA, Royster RL, Kon ND, Hines MH, Butterworth JF. Dobutamine antagonizes epinephrine's biochemical and cardiotonic effects: results of an in vitro model using human lymphocytes and a clinical study in patients recovering from cardiac surgery. Anesthesiology. 1998 Jul; 89(1):49-57.
Score: 0.041
-
Butterworth JF, Prielipp RC, Royster RL, Spray BJ, Kon ND, Wallenhaupt SL, Zaloga GP. Dobutamine increases heart rate more than epinephrine in patients recovering from aortocoronary bypass surgery. J Cardiothorac Vasc Anesth. 1992 Oct; 6(5):535-41.
Score: 0.027
-
Butterworth JF, Legault C, Royster RL, Hammon JW. Factors that predict the use of positive inotropic drug support after cardiac valve surgery. Anesth Analg. 1998 Mar; 86(3):461-7.
Score: 0.010